Plasticity and biological diversity of myeloid derived suppressor cells

Kerem Ben-Meir; Nira Twaik; Michal Baniyash

doi:10.1016/j.coi.2018.03.015

Plasticity and biological diversity of myeloid derived suppressor cells

Kerem Ben-Meir, Nira Twaik, Michal Baniyash

Department of Immunology and Cancer Research

Research output: Contribution to journal › Review article › peer-review

51 Scopus citations

Abstract

Myeloid derived suppressor cells (MDSCs) are immature myeloid cells characterized by diverse phenotypes and functions. They impair effector functions of immune cells and promote tumor growth, angiogenesis, and tissue damage. In pathologies characterized by chronic inflammation, MDSCs are arrested in their immature state and migrate from the bone marrow to the periphery and to the site of inflammation, where they mediate immunosuppression. When reaching new environments, which exhibit a different array of cytokines, chemokines, and pro-inflammatory mediators, MDSCs sense and adapt to the altered micro-environment by virtue of acquiring different suppressive features/functions that involve changing their cell fate, surface receptors, metabolism and intracellular as well as secreted molecules. This review summarizes some of the latest publications highlighting various layers of MDSC plasticity in relation to different pathologies. We discuss treatments capitalizing on MDSC plasticity aimed at combating MDSCs or manipulating their suppressive activity for improved therapy.

Original language	English
Pages (from-to)	154-161
Number of pages	8
Journal	Current Opinion in Immunology
Volume	51
DOIs	https://doi.org/10.1016/j.coi.2018.03.015
State	Published - Apr 2018

Bibliographical note

Funding Information:
The authors gratefully acknowledge the support of the Society of Research Associates of the Lautenberg Center and the Harold B Abramson Chair in Immunology. This work was supported by the Israel Science Foundation , the joint program between the Israel Science Foundation and the National Natural Science Foundation of China , the Israeli Ministry of Health , the Joint German-Israeli Research Program , the Israel Cancer Research Fund , the NOFAR Program of the Academic Research Office of the Chief Scientist , Ministry of Economy , the Melanoma Research Alliance Funds and the Joseph and Matilda Melnick Funds . The authors thank Hadas Ashkenazi-Preiser, Yaron Meirow, Leonor Daniel, Andrea Simona Safir and Eitan Yefe-Nof for reading and commenting on the manuscript.

Publisher Copyright:
© 2018 Elsevier Ltd

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.coi.2018.03.015

Cite this

@article{6679f9e70a3f4818ba295ef7e0fc673c,

title = "Plasticity and biological diversity of myeloid derived suppressor cells",

abstract = "Myeloid derived suppressor cells (MDSCs) are immature myeloid cells characterized by diverse phenotypes and functions. They impair effector functions of immune cells and promote tumor growth, angiogenesis, and tissue damage. In pathologies characterized by chronic inflammation, MDSCs are arrested in their immature state and migrate from the bone marrow to the periphery and to the site of inflammation, where they mediate immunosuppression. When reaching new environments, which exhibit a different array of cytokines, chemokines, and pro-inflammatory mediators, MDSCs sense and adapt to the altered micro-environment by virtue of acquiring different suppressive features/functions that involve changing their cell fate, surface receptors, metabolism and intracellular as well as secreted molecules. This review summarizes some of the latest publications highlighting various layers of MDSC plasticity in relation to different pathologies. We discuss treatments capitalizing on MDSC plasticity aimed at combating MDSCs or manipulating their suppressive activity for improved therapy.",

author = "Kerem Ben-Meir and Nira Twaik and Michal Baniyash",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Ltd",

year = "2018",

month = apr,

doi = "10.1016/j.coi.2018.03.015",

language = "אנגלית",

volume = "51",

pages = "154--161",

journal = "Current Opinion in Immunology",

issn = "0952-7915",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - Plasticity and biological diversity of myeloid derived suppressor cells

AU - Ben-Meir, Kerem

AU - Twaik, Nira

AU - Baniyash, Michal

PY - 2018/4

Y1 - 2018/4

N2 - Myeloid derived suppressor cells (MDSCs) are immature myeloid cells characterized by diverse phenotypes and functions. They impair effector functions of immune cells and promote tumor growth, angiogenesis, and tissue damage. In pathologies characterized by chronic inflammation, MDSCs are arrested in their immature state and migrate from the bone marrow to the periphery and to the site of inflammation, where they mediate immunosuppression. When reaching new environments, which exhibit a different array of cytokines, chemokines, and pro-inflammatory mediators, MDSCs sense and adapt to the altered micro-environment by virtue of acquiring different suppressive features/functions that involve changing their cell fate, surface receptors, metabolism and intracellular as well as secreted molecules. This review summarizes some of the latest publications highlighting various layers of MDSC plasticity in relation to different pathologies. We discuss treatments capitalizing on MDSC plasticity aimed at combating MDSCs or manipulating their suppressive activity for improved therapy.

AB - Myeloid derived suppressor cells (MDSCs) are immature myeloid cells characterized by diverse phenotypes and functions. They impair effector functions of immune cells and promote tumor growth, angiogenesis, and tissue damage. In pathologies characterized by chronic inflammation, MDSCs are arrested in their immature state and migrate from the bone marrow to the periphery and to the site of inflammation, where they mediate immunosuppression. When reaching new environments, which exhibit a different array of cytokines, chemokines, and pro-inflammatory mediators, MDSCs sense and adapt to the altered micro-environment by virtue of acquiring different suppressive features/functions that involve changing their cell fate, surface receptors, metabolism and intracellular as well as secreted molecules. This review summarizes some of the latest publications highlighting various layers of MDSC plasticity in relation to different pathologies. We discuss treatments capitalizing on MDSC plasticity aimed at combating MDSCs or manipulating their suppressive activity for improved therapy.

UR - http://www.scopus.com/inward/record.url?scp=85044599039&partnerID=8YFLogxK

U2 - 10.1016/j.coi.2018.03.015

DO - 10.1016/j.coi.2018.03.015

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

C2 - 29614426

AN - SCOPUS:85044599039

SN - 0952-7915

VL - 51

SP - 154

EP - 161

JO - Current Opinion in Immunology

JF - Current Opinion in Immunology

ER -

Plasticity and biological diversity of myeloid derived suppressor cells

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this